Method for killing yeast and sporular microorganisms with haloperoxidase-containing compositions
AssigneeExOxEmis, Inc.
InventorRobert C. Allen
Life of this patent
Estimating the term…
Loading patent…
AssigneeExOxEmis, Inc.
InventorRobert C. Allen
Estimating the term…
Methods and compositions are provided for killing or inhibiting the growth of yeast or sporular microorganisms by contacting the microorganisms, in the presence of a peroxide and chloride or bromide, with a haloperoxidase and at least one antimicrobial activity enhancing agent. Suitable antimicrobial activity enhancing agents include certain .alpha.-amino acids, and are preferably compounds of the formula: ##STR1## wherein R.sub.1 is hydrogen, an unsubstituted, or hydroxy or amino substituted, straight or branched chain alkyl group having from 1 to 6 carbon atoms, or an unsubstituted, or hydroxy or amino substituted arylalky group having from 7 to 12 carbon atoms, and R.sub.2 is hydrogen or a straight or branched chain alkyl group having from 1 to 6 carbon atoms. The significantly enhanced haloperoxidase antiyeast and antispore activities make the methods and compositions of the invention highly useful in the therapeutic or prophylactic antiseptic treatment of human or animal subjects and in in vitro applications for disinfection or sterilization of vegetative microbes, yeasts, and bacterial and fungal spores. Suitable haloperoxidases for use in the methods and compositions of the invention include eosinophil peroxidase (EPO) and myeloperoxidase (MPO). Representative antimicrobial activity enhancing agents of the invention include .alpha.-amino acids selected from the group consisting of glycine and the l- or d-enantiomers of alanine, valine, leucine, isoleucine, serine, threonine, lysine, phenylalanine, tyrosine, and the alkyl esters thereof.
An in vitro method for killing or inhibiting the growth of sporulating microorganisms selected from the group consisting of bacteria, yeast and fungi, comprising contacting said sporulating microorganisms, in the presence of a halide selected from the group consisting of chloride and bromide, with a composition comprising a haloperoxidase and at least one agent of the formula:
A method of disinfecting a medical device which comprises contacting the device, in the presence of a halide selected from the group consisting of chloride and bromide, with a disinfecting-sterilizing solution which comprises from 0.1 pmol/ml to 500 pmol/ml of myeloperoxidase, eosinophil peroxidase or combinations thereof, and from 0.005 .mu.mol/ml to 50 .mu.mol/ml of an .alpha.-amino acid selected from the group consisting of glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine and the alkyl esters of any of the members of the group, in a liquid carrier;
A method of disinfecting a contact lens which comprises contacting the lens, in the presence of a halide selected from the group consisting of chloride and bromide, with an ophthalmic solution which comprises from 0.1 pmol/ml to 500 pmol/ml of myeloperoxidase, eosinophil peroxidase or combinations thereof, and from 0.005 .mu.mol/ml to 50 .mu.mol/ml of an .alpha.-amino acid selected from the group consisting of glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine and the alkyl esters of any of the members of the group, in an ophthalmically acceptable liquid carrier;
Dependencies are inferred from the claim text.